Skip to main content

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Recruiting · NCT06388421

Conditions: Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Interstitial Lung Disease

At a glance

Research payments reported, 2025
$958,166
U.S. investigators named
46
Sites paid
44
Planned or actual enrollment
900

About the trial

Sponsor
United Therapeutics
Tested
Prospective study assessments (other)
Dates
Started 2025-01-23; completion 2030-11-30
Results posted
Not yet

This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

From ClinicalTrials.gov, last updated 2026-08-26. Full record, eligibility and contacts (opens in a new tab)

Industry funding

United Therapeutics Corporation reported $958,166 in research payments for this study in 2025 (135 payments).

Products named: Tyvaso

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Thomas Jefferson University $61,060
  • Temple University of the Commonwealth System of Higher Education $50,143
  • Duke University Department of Medicine $44,650
  • Morristown Medical Center, NJ $36,545
  • Biomedical Research Alliance of New York LLC $35,375
  • The Ohio State University $35,075
  • NYU Grossman School of Medicine $34,084
  • Advocate Aurora Research Institute LLC $33,501
  • Northwestern University $30,829
  • The University of South Florida $30,223
  • University of New Mexico Hsc $29,320
  • Legacy Emanuel Medical Center, OR $28,719
  • Baylor Research Institute $27,237
  • Intermountain Health Utah Valley Hospital, UT $26,921
  • Bend Memorial Clinic PC $24,539
  • Medical University of South Carolina $24,074
  • University of Cincinnati $23,495
  • Ohsu Hospital and Clinics, OR $22,380
  • Anmed Health, SC $22,135
  • Adventhealth Orlando, FL $21,660
  • Norton Healthcare Inc $20,855
  • Kumc Research Institute Inc $19,710
  • Nch Research Institute Inc $18,843
  • The Methodist Hospital Research Institute $18,210
  • The University of Texas Health $18,189
  • Virginia Commonwealth University $15,590
  • Loyola University of Chicago $15,320
  • Center for Biomedical Research $14,841
  • The University of Texas Southwestern Medical Center $14,280
  • Hospital of Univ of Pennsylvania, PA $13,900
  • East Carolina University $13,850
  • St Luke S Health Network $13,404
  • Louisiana State University Health Sciences Center $12,800
  • University of Colorado Denver $12,500
  • The Washington University $11,900
  • Pulmonix, LLC $11,858
  • Oklahoma Heart Research and Education Foundation $11,692
  • Pulmonary Assoc of Richmond Inc $10,644
  • Intercoastal Medical Group $9,149
  • Wakemed, Raleigh Campus, NC $7,500
  • Medical College of Wisconsin Inc $7,500
  • Hartford Hospital, CT $7,241
  • University Physicians Internal $6,500
  • Allianze Pulmonary Research LLC $5,741
  • $4,184

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.